Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
Abroad (travel likely)RecruitingPHASE2
Conditions
Hepatitis B, Chronic
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
St Vincents Hospital Melbourne, Fitzroy, Victoria, Australia
Queen Mary Hospital - PPDS, Hong Kong, China
New Zealand Clinical Research, Grafton, Auckland, New Zealand
National University Hospital - Singapore, Singapore, Singapore
Asan Medical Center, Seoul, South Korea
Chiayi Christian Hospital, Chiayi City, Taiwan
E-DA Hospital, Kaohsiung City, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Study leads
Audrey Lau, MD, PhD
Study Chair
AusperBio Therapeutics Inc.